Ngā hua rapu kaituhi :: APM

1

Hyperlactatemia and Hepatic Abnormalities in 10 Human Immunodeficiency Virus-Infected Patients Receiving Nucleoside Analogue Combination Regimens mā J Tyler Lonergan, Cynthia Behling, H. PFANDER, T HASSANEIN, W. Christopher Mathews

I whakaputaina 2000

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
2

Evidence and Recommendations for Imaging Liver Fat in Children, Based on Systematic Review mā Hannah I. Awai, Kimberly P. Newton, Claude B. Sirlin, Cynthia Behling, Jeffrey B. Schwimmer

I whakaputaina 2013

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Revisão

Tiaki ki tētahi rārangi

I tiakina i:
3

Pediatric Nonalcoholic Fatty Liver Disease mā Heather Patton, Claude B. Sirlin, Cynthia Behling, Michael S. Middleton, Jeffrey B. Schwimmer, Joel E. Lavine

I whakaputaina 2006

Whiwhi kuputuhi katoa
Revisão

Tiaki ki tētahi rārangi

I tiakina i:
4

Symptoms and quality of life in obese children and adolescents with non‐alcoholic fatty liver disease mā Kristin D. Kistler, Jean P. Molleston, Aynur Ünalp, Stephen H. Abrams, Cynthia Behling, Jeffrey B. Schwimmer

I whakaputaina 2009

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
5

Longitudinal Assessment of High Blood Pressure in Children with Nonalcoholic Fatty Liver Disease mā Jeffrey B. Schwimmer, Anne Zepeda, Kimberly P. Newton, Stavra A. Xanthakos, Cynthia Behling, Erin Hallinan, Michele Donithan, James Tonascia

I whakaputaina 2014

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
6

Analysis of gene expression profiles in normal and neoplastic ovarian tissue samples identifies candidate molecular markers of epithelial ovarian cancer mā John Welsh, Patrick P. Zarrinkar, Lisa M. Sapinoso, S Kern, Cynthia Behling, Bradley J. Monk, David J. Lockhart, Robert A. Burger, Garret M. Hampton

I whakaputaina 2001

Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
7

Clinical use of hyaluronic acid as a predictor of fibrosis change in hepatitis C mā Keyur Patel, Adrianne LaJoie, Shanon Heaton, Stephen Pianko, Cynthia Behling, David Bylund, PAULJ POCKROS, Lawrence M. Blatt, Andrew Conrad, John G. McHutchison

I whakaputaina 2003

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
8

Association Between Metabolic Syndrome and Liver Histology Among Children With Nonalcoholic Fatty Liver Disease mā Heather Patton, Katherine P. Yates, Aynur Ünalp–Arida, Cynthia Behling, Terry T.‐K. Huang, Philip Rosenthal, Arun J. Sanyal, Jeffrey B. Schwimmer, Joel E. Lavine

I whakaputaina 2010

Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
9

Associations between histologic features of nonalcoholic fatty liver disease (NAFLD) and quantitative diffusion‐weighted MRI measurements in adults mā P. Murphy, Jonathan Hooker, Brandon Ang, Tanya Wolfson, Anthony Gamst, Mark Bydder, Michael S. Middleton, Michael R. Peterson, Cynthia Behling, Rohit Loomba, Claude B. Sirlin

I whakaputaina 2014

Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
10

Clinical utility of 30% relative decline in MRI-PDFF in predicting fibrosis regression in non-alcoholic fatty liver disease mā Nobuharu Tamaki, Nagambika Munaganuru, Jinho Jung, Aed Qas Yonan, Rohan Loomba, Richele Bettencourt, Veeral Ajmera, Mark A. Valasek, Cynthia Behling, Claude B. Sirlin, Rohit Loomba

I whakaputaina 2021

Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
11

Magnetic resonance elastography plus Fibrosis‐4 versus FibroScan–aspartate aminotransferase in detection of candidates for pharmacological treatment of NASH‐related fibrosis mā Nobuharu Tamaki, Kento Imajo, Suzanne R. Sharpton, Jinho Jung, Nobuyoshi Kawamura, Masato Yoneda, Mark A. Valasek, Cynthia Behling, Claude B. Sirlin, Atsushi Nakajima, Rohit Loomba

I whakaputaina 2021

Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
12

A prospective study on the prevalence of NAFLD, advanced fibrosis, cirrhosis and hepatocellular carcinoma in people with type 2 diabetes mā Veeral Ajmera, Sandra Cepin, Kaleb Tesfai, Heather Hofflich, Karen Cadman, Scarlett Lopez, Egbert Madamba, Ricki Bettencourt, Lisa Richards, Cynthia Behling, Claude B. Sirlin, Rohit Loomba

I whakaputaina 2022

Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
13

Artificial intelligence scoring of liver biopsies in a phase ii trial of semaglutide in non-alcoholic steatohepatitis mā Vlad Ratziu, Sven Francque, Cynthia Behling, Vanja Cejvanovic, Helena Cortez‐Pinto, Janani Iyer, Niels Krarup, Quang Le, Anne‐Sophie Sejling, Dina Tiniakos, Stephen A. Harrison

I whakaputaina 2023

Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
14

Magnetic resonance imaging and liver histology as biomarkers of hepatic steatosis in children with nonalcoholic fatty liver disease mā Jeffrey B. Schwimmer, Michael S. Middleton, Cynthia Behling, Kimberly P. Newton, Hannah I. Awai, Melissa Paiz, Jessica Lam, Jonathan Hooker, Gavin Hamilton, John Fontanesi, Claude B. Sirlin

I whakaputaina 2014

Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
15

Use of 5-fluorouracil and survival in patients with microsatellite-unstable colorectal cancer mā John M. Carethers, Edward J. Smith, Cynthia Behling, Lanchinh Nguyen, Akihiro Tajima, Ryan T. Doctolero, Betty L. Cabrera, Ajay Goel, Christian Arnold, Katsumi Miyai, C. Richard Boland

I whakaputaina 2004

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
16

Magnetic resonance elastography predicts advanced fibrosis in patients with nonalcoholic fatty liver disease: A prospective study mā Rohit Loomba, Tanya Wolfson, Brandon Ang, Jonathan Hooker, Cynthia Behling, Michael R. Peterson, Mark A. Valasek, Grace Lin, David A. Brenner, Anthony Gamst, Richard L. Ehman, Claude B. Sirlin

I whakaputaina 2014

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
17

Efruxifermin in non-alcoholic steatohepatitis: a randomized, double-blind, placebo-controlled, phase 2a trial mā Stephen A. Harrison, Peter Ruane, B. Freilich, Guy Neff, Rashmee Patil, Cynthia Behling, Chen Hu, Erica Fong, Brittany de Temple, Erik J. Tillman, Tim Rolph, Andrew Cheng, Kitty Yale

I whakaputaina 2021

Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
18

Prevalence of Prediabetes and Type 2 Diabetes in Children With Nonalcoholic Fatty Liver Disease mā Kimberly P. Newton, Jiayi Hou, Nancy A. Crimmins, Joel E. Lavine, Sarah E. Barlow, Stavra A. Xanthakos, Jonathan A. Africa, Cynthia Behling, Michele Donithan, Jeanne M. Clark, Jeffrey B. Schwimmer

I whakaputaina 2016

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
19

Clinical Utility of Combined MRI-PDFF and ALT Response in Predicting Histologic Response in Nonalcoholic Fatty Liver Disease mā Daniel Q. Huang, Suzanne R. Sharpton, Maral Amangurbanova, Nobuharu Tamaki, Claude B. Sirlin, Rohit Loomba, Ricki Bettencourt, Egbert Madamba, Jinho Jung, Harris Siddiqi, Lisa Richards, Mark A. Valasek, Cynthia Behling

I whakaputaina 2022

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Carta

Tiaki ki tētahi rārangi

I tiakina i:
20

Alanine Aminotransferase and Gamma‐Glutamyl Transpeptidase Predict Histologic Improvement in Pediatric Nonalcoholic Steatohepatitis mā Kimberly P. Newton, Joel E. Lavine, Laura Wilson, Cynthia Behling, Miriam B. Vos, Jean P. Molleston, Philip Rosenthal, Tamir Miloh, Mark Fishbein, Ajay K. Jain, Karen F. Murray, Jeffrey B. Schwimmer

I whakaputaina 2020

Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i: